Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 56021/0006.
Morphine sulfate 2mg in 1mL Solution for Injection
Morphine Sulfate 2mg in 1mL Solution for Injection
Morphine Sulfate
1. What Morphine Sulfate Injection is and what it is used for
2. What you need to know before you use Morphine Sulfate Injection
3. How to use Morphine Sulfate Injection
4. Possible Side Effects
5. How to store Morphine Sulfate Injection
6. Contents of the pack and other information
This medicine contains morphine sulfate which is an opioid, which can cause addiction. You can get withdrawal symptoms if you stop using it suddenly
This medicine has been prescribed for you for the long term relief of moderate to severe pain, such as the pain caused by surgery, heart attacks and cancer. This medicine also helps to reduce the anxiety and sleeplessness which may be caused by the pain. It contains morphine sulfate which belongs to a class of medicines called opioids, which are ‘pain relievers’. This medicine is a solution for injection that has been prepared in water so that it can be used with specially designed pumps which provide a continuous injection into the body.
This medicine has been prescribed to you and should not be given to anyone else.
Opioids can cause addiction and you may get withdrawal symptoms if you stop using it suddenly. Your doctor, pharmacist or nurse should have explained how long you will be using it for and when it is appropriate to stop, how to do this safely.
Check with your doctor if you are concerned about any of the above.
Talk to your doctor, pharmacist or nurse before using this medicine if you:
Check with your doctor if you are concerned about any of the above. This medicine is only suitable for long lasting pain and is not intended for pain which only lasts for short periods.
Using this medicine regularly, particularly for a long time, can lead to addiction. Your doctor, pharmacist or nurse should have explained how long you will be using it for and when it is appropriate to stop, how to do this safely.
Rarely, increasing the dose of this medicine can make you more sensitive to pain. If this happens, you need to speak to your doctor, pharmacist or nurse about your treatment.
Addiction can cause withdrawal symptoms when you stop using this medicine. Withdrawal symptoms can include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, loss of appetite, shaking, shivering or sweating. Your doctor, pharmacist or nurse will discuss with you how to gradually reduce your dose before stopping the medicine. It is important that you do not stop using the medicine suddenly as you will be more likely to experience withdrawal symptoms.
Opioids should only be used by those they are prescribed for. Do not give your medicine to anyone else. Using higher doses, or more frequent doses of opioid, may increase the risk of addiction. Overuse and misuse can lead to overdose and/or death.
Tolerance, dependence, and addiction
This medicine contains morphine which is an opioid medicine. Repeated use of opioids can result in the drug being less effective (you become accustomed to it, known as tolerance). Repeated use of Morphine Sulfate Injection can also lead to dependence, abuse, and addiction, which may result in life-threatening overdose. The risk of these side effects can increase with a higher dose and longer duration of use.
Dependence or addiction can make you feel that you are no longer in control of how much medicine you need to take or how often you need to take it.
The risk of becoming dependent or addicted varies from person to person. You may have a greater risk of becoming dependent on or addicted to Morphine Sulfate Injection if:
If you notice any of the following signs whilst taking Morphine Sulfate Injection, it could be a sign that you have become dependent or addicted:
If you notice any of these signs, speak to your doctor to discuss the best treatment pathway for you, including when it is appropriate to stop and how to stop safely (See section 3, If you stop taking Morphine Sulfate Injection).
Take special care with Morphine Sulfate Injection:
Acute generalized exanthematous pustulosis (AGEP) has been reported in association with Morphine Sulfate Injection treatment. Symptoms usually occur within the first 10 days of treatment. Tell your doctor if you have ever developed a severe skin rash or skin peeling, blistering and/or mouth sores after taking Morphine Sulfate Injection or other opioids. Stop using Morphine Sulfate Injection and seek medical attention immediately, if you notice any of the following symptoms: blistering, widespread scaly skin or pus-filled spots together with fever.
Sleep-related breathing disorders
Morphine Sulfate Injection can cause sleep-related breathing disorders such as sleep apnoea (breathing pauses during sleep) and sleep related hypoxemia (low oxygen level in the blood). The symptoms can include breathing pauses during sleep, night awakening due to shortness of breath, difficulties to maintain sleep or excessive drowsiness during the day. If you or another person observe these symptoms, contact your doctor. A dose reduction may be considered by your doctor.
Contact your doctor if you experience severe upper abdominal pain possibly radiating to the back, nausea, vomiting or fever as this could be symptoms associated with inflammation of the pancreas (pancreatitis) and the biliary tract system.
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
This is especially important if you are taking any of the medicines mentioned below or medicines for:
However, if your doctor does prescribe Morphine Sulfate Injection together with sedative medicines the dose and duration of concomitant treatment should be limited by your doctor.
Please tell your doctor about all sedative medicines you are taking, and follow your doctor’s dose recommendation closely. It could be helpful to inform friends or relatives to be aware of the signs and symptoms stated above. Contact your doctor when experiencing such symptoms.
Do not use Morphine Sulfate Injection if you are pregnant or think you might be pregnant unless you have discussed this with your doctor, pharmacist or nurse and the benefits of treatment are considered to outweigh the potential harm to the baby.
If you use Morphine Sulfate Injection during pregnancy, your baby may become dependent and experience withdrawal symptoms after the birth which may need to be treated.
Do not use Morphine Sulfate Injection while you are breastfeeding as morphine sulfate passes into breast milk and will affect your baby.
You must not use machinery whilst using this medicine. The medicine can affect your ability to drive as it may make you sleepy or dizzy.
Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while using this medicine.
This medicine contains 3.6mg sodium (main component of cooking/table salt) in each mL. This is equivalent to 0.2% of the WHO recommended daily intake of 2g sodium for an adult.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Before starting treatment and regularly during treatment, your doctor will discuss with you what you may expect from using Morphine Sulfate Injection, when and how long you need to take it, when to contact your doctor, and when you need to stop it (see also, If you stop taking Morphine Sulfate Injection, in this section).
The doctor will decide what dose of this medicine you should be given. It will need to be given by a nurse or doctor using a syringe and needle to draw up the injection for administration.
The syringe may be put into a small machine which allows a slow continuous injection of this medicine to be given.
There is a procedure called Patient Controlled Analgesia (PCA) where you will be provided with a button to press when you are in pain and the machine will then give you a small amount of this medicine. There will be a safety device on the machine so that you cannot exceed the maximum number of doses.
Let your doctor or nurse know if your pain gets worse while you are using this medicine. Your doctor may want to increase your dose of the medicine and/or give you some extra medicines for the pain.
Tell your doctor as soon as possible. If you are a medical practitioner administering this medicine please refer to the Summary of Product Characteristics.
People who have taken an overdose may get pneumonia from inhaling vomit or foreign matter, symptoms may include breathlessness, cough and fever. People who have taken an overdose may also have breathing difficulties leading to unconsciousness or even death.
The dose should be given as soon as it is remembered. The next dose should be given at the usual time. Do not take a double dose to make up for a forgotten dose.
Do not suddenly stop using this medicine. If you want to stop using this medicine, discuss this with your doctor, pharmacist or nurse first. They will tell you how to do this, usually by reducing the dose gradually so that any unpleasant withdrawal effects are kept to a minimum. Withdrawal symptoms such as restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating may occur if you suddenly stop using this medicine.
Like all medicines, this medicine can cause side effects although not everybody gets them.
Stop using Morphine Sulfate Injection and seek medical attention immediately if you notice any of the following symptoms:
This could be a condition called Acute Generalized Exanthematous Pustulosis (AGEP).
If you are affected by these important side effects contact a doctor immediately.
The most common side effects are respiratory depression (slow or shallow breathing), nausea, vomiting, constipation, feeling more sleepy than normal and feeling confused.
Other common side effects are:
Side Effects of Unknown Frequency are:
Drug Withdrawal
When you stop using Morphine Sulfate Injection, you may experience drug withdrawal symptoms, which include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating.
If you notice any of the following signs whilst using Morphine Sulfate Injection, it could be a sign that you have become addicted.
If you notice any of these signs, it is important you talk to your doctor, pharmacist or nurse.
Tell your doctor, nurse or pharmacist immediately if you think you have any of these, or other problems.
Further side effects can occur during long-term treatment with this medicine. These side effects include:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: Website: www.mhra.gov.uk/yellowcard or Search for MHRA Yellow Card in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. This medicine has an expiry date printed on the bottle (vial) and carton label. Before use the doctor or nurse will check the product has not passed this date and that the medicine does not show any sign of deterioration. The expiry date refers to the last day of the month.
After the expiry date return any unused medicine to a pharmacy.
Store this medicine away from sunlight and below 25ºC.
This medicine is a clear and colourless or almost colourless solution. This medicine is available in 50mL single use vials. The medicine is packed into cartons containing one vial or 10 vials. Both pack sizes may not be available at the same time.
This leaflet was last revised in: February 2024
PL 56021/0006
PIL/6/16